Abiopharma

Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET

IMAX Blasts Off With $28 Million Opening Weekend For Amazon/MGM’s “Project Hail Mary”

Rubico Announces Filing of 2025 Annual Report on Form 20-F

Draganfly and Palladyne AI Achieve Integration Milestone Advancing Autonomous Swarm Capabilities

Alto Ingredients, Inc. to Participate in H.C. Wainwright’s Renewable Fuels Virtual Day

EZCORP to Host Annual Meeting of Stockholders on Thursday, March 26, 2026

Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders

Stran & Company Schedules 2025 Fiscal Year Financial Results and Business Update Conference Call

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update